Evidence map›Paper›PMID 37460617›Full record

ArticleScientific reports2023

Openable artificial intestinal tract device integrated with a permeable filter for evaluating drug permeation through cells.

Satoshi Konishi, Shingo Ishibashi, Shiho Shimizu, Keita Watanabe, Rodi Abdalkader, Takuya Fujita

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Satoshi KonishiDepartment of Mechanical Engineering, College of Science and Engineering, Ritsumeikan University, Kusatsu, 525-8577, Japan. konishi@se.ritsumei.ac.jp.
Shingo IshibashiGraduate Course of Science and Engineering, Ritsumeikan University, Kusatsu, 525-8577, Japan.
Shiho ShimizuGraduate Course of Science and Engineering, Ritsumeikan University, Kusatsu, 525-8577, Japan.
Keita WatanabeGraduate School of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Noji-Higashi, Kusatsu, Shiga, 525-8577, Japan.
Rodi AbdalkaderRitsumeikan Global Innovation Research Organization, Ritsumeikan University, Kusatsu, 525-8577, Japan.
Takuya FujitaRitsumeikan Global Innovation Research Organization, Ritsumeikan University, Kusatsu, 525-8577, Japan.
Ritsumeikan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organs-on-chips using cultured cells have been developed and applied for evaluating in vitro biological phenomena. We previously reported an openable artificial intestinal tract system, as an in vitro model of the small intestine, for in vitro drug screening. The intestinal tract device could be transformed using an integrated artificial muscle actuator. An initial flat state was suitable for cell culture, and the transformed tubular structure was used as a fluidic channel for perfusion tests. The previously developed intestinal tract system could be used to evaluate drug absorption by cells through perfusion testing. This study presents an improved artificial intestinal tract system for analysis of drug permeation, in addition to absorption. Permeable filters were integrated into the intestinal tract device. Integration of additional filters into the design of the existing artificial muscle actuator was accomplished by considering device performance and available filter locations. Filter permeability was evaluated by perfusion testing. MDCK-II cells were cultured on the device and visually and electrically evaluated. The openable device, equipped with new functions for further pharmacokinetic analysis, could perform and evaluate drug disposition using cultured cells. We anticipate that the improved, openable organ-on-a-chip device system will contribute to advances in in vitro drug screening technology.

Indexed as

Gastrointestinal TractIntestinesAdministration, OralAnimalsCell Culture TechniquesDogsIntestinal AbsorptionMadin Darby Canine Kidney CellsPermeability

Identifiers

PMID37460617
PMCPMC10352237
OpenAlexW4384523768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.